US3766167A
(en)
|
1971-03-26 |
1973-10-16 |
Research Corp |
Orally active anticoagulant
|
DE2426586A1
(de)
|
1973-06-14 |
1975-01-09 |
Opocrin Srl |
Verfahren zur herstellung von glukuronil-glukosamin-glykan-sulfaten mit antilipaemischer wirkung
|
IT1083903B
(it)
|
1977-08-09 |
1985-05-25 |
Lobo Srl |
Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
|
FR2478646A2
(fr)
|
1980-03-20 |
1981-09-25 |
Choay Sa |
Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
|
USRE35770E
(en)
|
1978-11-06 |
1998-04-14 |
Choay, S.A. |
Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them
|
US4692435A
(en)
|
1978-11-06 |
1987-09-08 |
Choay, S.A. |
Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation
|
FR2440376A1
(fr)
|
1978-11-06 |
1980-05-30 |
Choay Sa |
Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
|
US4500519A
(en)
|
1978-11-06 |
1985-02-19 |
Choay S.A. |
Mucopolysaccharides having biological properties, preparation and method of use
|
CA1136620A
(en)
|
1979-01-08 |
1982-11-30 |
Ulf P.F. Lindahl |
Heparin fragments having selective anticoagulation activity
|
GB2051103A
(en)
|
1979-04-11 |
1981-01-14 |
Choay Sa |
Heparin fractions
|
US4826827A
(en)
|
1979-10-05 |
1989-05-02 |
Choay S.A. |
Short chained oligosaccharides having biological properties, a process for making the same and the use thereof as drugs
|
IL61201A
(en)
|
1979-10-05 |
1984-09-30 |
Choay Sa |
Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
|
US4281108A
(en)
|
1980-01-28 |
1981-07-28 |
Hepar Industries, Inc. |
Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
|
FR2482611B1
(fr)
|
1980-05-14 |
1986-03-07 |
Pharmindustrie |
Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
|
FR2482603A1
(fr)
|
1980-05-14 |
1981-11-20 |
Pharmindustrie |
Nouveaux esters d'heparine utilisables pour la preparation de medicaments, et procedes pour leur preparation
|
US4438261A
(en)
|
1980-05-19 |
1984-03-20 |
Riker Laboratories, Inc. |
Anticoagulant substance
|
US4351938A
(en)
|
1980-05-19 |
1982-09-28 |
Riker Laboratories, Inc. |
Anticoagulant substance
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
FR2503714B1
(fr)
|
1981-04-10 |
1986-11-21 |
Choay Sa |
Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
|
FR2504928A1
(fr)
|
1981-04-29 |
1982-11-05 |
Choay Sa |
Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
|
US4396762A
(en)
|
1981-08-24 |
1983-08-02 |
Massachusetts Institute Of Technology |
Heparinase derived anticoagulants
|
CA1195322A
(en)
|
1982-07-19 |
1985-10-15 |
Eduardo Amaya |
Process for manufacturing low molecular weight heparins by depolymerization of normal heparin
|
US4533549A
(en)
|
1983-01-04 |
1985-08-06 |
Lasker Sigmund E |
Antithrombotic agent
|
IT1195497B
(it)
|
1983-03-08 |
1988-10-19 |
Opocrin Spa |
Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
|
US4686388A
(en)
|
1985-03-12 |
1987-08-11 |
Pitney Bowes Inc. |
Integrated circuit substrate bias selection circuit
|
US5106734A
(en)
|
1986-04-30 |
1992-04-21 |
Novo Nordisk A/S |
Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight heparin
|
DK196886D0
(da)
|
1986-04-30 |
1986-04-30 |
Novo Industri As |
Fremstilling af polysaccharider
|
DK196986D0
(da)
|
1986-04-30 |
1986-04-30 |
Novo Industri As |
Fremstilling af polysaccharider
|
IT1213384B
(it)
|
1986-11-24 |
1989-12-20 |
Lab Derivati Organici Mediolan |
Processo per la preparazione controllata di gilcosaminoglicani a basso peso molecolare.
|
US4833155A
(en)
|
1986-11-25 |
1989-05-23 |
Syntex (U.S.A.) Inc. |
3-(ω-(3,5,-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles, and anti-inflammatory uses thereof
|
ES2003197A6
(es)
|
1987-01-05 |
1988-10-16 |
Rovi Lab Farmaceut Sa |
Procedimiento de despolimerizacion de la heparina para la obtencion de una heparina de bajo peso molecular dotada de actividad antitrombotica
|
FR2614026B1
(fr)
|
1987-04-16 |
1992-04-17 |
Sanofi Sa |
Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
|
EP0337327A1
(en)
|
1988-04-09 |
1989-10-18 |
Bioiberica, S.A. |
Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
|
IT1234508B
(it)
|
1988-06-10 |
1992-05-19 |
Alfa Wassermann Spa |
Derivati eparinici e procedimento per la loro preparazione
|
US4981955A
(en)
|
1988-06-28 |
1991-01-01 |
Lopez Lorenzo L |
Depolymerization method of heparin
|
IT1234826B
(it)
|
1989-01-30 |
1992-05-29 |
Alfa Wassermann Spa |
Derivati eparinici e procedimento per la loro preparazione
|
IE64121B1
(en)
|
1989-10-04 |
1995-07-12 |
Akzo Nv |
Sulphated glycosaminoglycuronan with antithrombotic activity
|
US5378829A
(en)
|
1990-04-23 |
1995-01-03 |
Akzo N.V. |
Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
|
FR2663639B1
(fr)
|
1990-06-26 |
1994-03-18 |
Rhone Poulenc Sante |
Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
|
USRE38743E1
(en)
|
1990-06-26 |
2005-06-14 |
Aventis Pharma S.A. |
Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
|
US5821223A
(en)
|
1990-09-14 |
1998-10-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
|
US5280016A
(en)
|
1991-03-29 |
1994-01-18 |
Glycomed Incorporated |
Non-anticoagulant heparin derivatives
|
US5849721A
(en)
|
1992-02-07 |
1998-12-15 |
Rhone-Poulenc Rorer S.A. |
Sulfated polysaccharides obtained from heparin, preparation process, pharmaceutical composition and use thereof
|
US5541095A
(en)
|
1992-06-16 |
1996-07-30 |
University Of Massachusetts Medical Center |
Glycosaminoglycan specific sulfotransferases
|
FR2704861B1
(fr)
|
1993-05-07 |
1995-07-28 |
Sanofi Elf |
Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
|
JP3818676B2
(ja)
|
1994-07-22 |
2006-09-06 |
生化学工業株式会社 |
ヘパラン硫酸6−o−硫酸基転移酵素
|
US5919673A
(en)
|
1995-03-22 |
1999-07-06 |
The Scripps Research Institute |
One-pot enzymatic sulfation process using 3'-phosphoadenosine-5'-phosphosulfate and recycled phosphorylated adenosine intermediates
|
JP3672359B2
(ja)
|
1995-07-24 |
2005-07-20 |
生化学工業株式会社 |
ヘパラン硫酸 2−o−硫酸基転移酵素
|
US6861254B1
(en)
|
1997-10-24 |
2005-03-01 |
Massachusetts Institute Of Technology |
Heparan sulfate D-glucosaminyl 3-O-sulfotransferases, and uses therefor
|
US20060188966A1
(en)
|
1998-04-02 |
2006-08-24 |
Deangelis Paul L |
Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
|
US8088604B2
(en)
|
1998-04-02 |
2012-01-03 |
The Board Of Regents Of The University Of Oklahoma |
Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
|
DE69934890D1
(de)
|
1998-06-16 |
2007-03-08 |
Univ Oklahoma |
Glykosulfopeptide und verfahren zu deren herstellung und deren verwendung
|
US6255088B1
(en)
|
1999-05-11 |
2001-07-03 |
The Scripps Research Institute |
Enzymatic sulfation of biomolecules
|
DE10002005A1
(de)
|
2000-01-19 |
2001-08-09 |
Bosch Gmbh Robert |
Zerstäubungsdüse
|
CN1311305A
(zh)
*
|
2000-03-02 |
2001-09-05 |
上海博德基因开发有限公司 |
一种新的多肽——硫酸乙酰肝素3-0-磺基转移酶19和编码这种多肽的多核苷酸
|
EP1319183B1
(en)
|
2000-09-12 |
2009-03-25 |
Massachusetts Institute Of Technology |
Methods and products related to low molecular weight heparin
|
FR2814463B1
(fr)
|
2000-09-22 |
2002-11-15 |
Sanofi Synthelabo |
Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
|
ITMI20010397A1
(it)
|
2001-02-27 |
2002-08-27 |
Giorgio Zoppetti |
Derivati altamente n,o-solfatati del polisaccaride k5 e loro preparazione
|
CA2441984A1
(en)
|
2001-03-28 |
2002-10-10 |
Massachusetts Institute Of Technology |
Methods of 6-o-sulfating polysaccharides and 6-o-sulfated polysaccharide preparations
|
US8580290B2
(en)
|
2001-05-08 |
2013-11-12 |
The Board Of Regents Of The University Of Oklahoma |
Heparosan-based biomaterials and coatings and methods of production and use thereof
|
WO2002089742A2
(en)
|
2001-05-08 |
2002-11-14 |
The Board Of Regents Of The University Of Oklahoma |
Heparin/heparosan synthase and methods of making and using same
|
TWI281861B
(en)
|
2002-01-29 |
2007-06-01 |
Sanofi Aventis |
A pharmaceutical composition comprising SANORG 34006 for treatment and secondary prophylaxis of venous thromboembolic events in patients with deep venous thrombosis
|
WO2004005475A2
(en)
|
2002-07-05 |
2004-01-15 |
University Of North Carolina At Chapel Hill |
Purified and isolated heparan sulfate 3-o-sulfotransferase isoform 5 nucleic acids and polypeptides and therapeutic and screening methods using same
|
WO2004017910A2
(en)
*
|
2002-08-23 |
2004-03-04 |
Neose Technologies, Inc. |
Total synthesis of heparin
|
US20040147469A1
(en)
|
2002-11-01 |
2004-07-29 |
Case Western Reserve University |
Methods of inhibiting glial scar formation
|
AU2003293122A1
(en)
|
2002-11-27 |
2004-06-23 |
Massachusetts Institute Of Technology |
Methods for synthesizing polysaccharides
|
US7655445B2
(en)
*
|
2003-11-12 |
2010-02-02 |
Massachusetts Institute Of Technology |
Methods for synthesis of sulfated saccharides
|
WO2006023487A2
(en)
*
|
2004-08-16 |
2006-03-02 |
Massachusetts Institute Of Technology |
Rapid two-step synthesis of anti-coagulants
|
US20060154894A1
(en)
|
2004-09-15 |
2006-07-13 |
Massachusetts Institute Of Technology |
Biologically active surfaces and methods of their use
|
CA2594013A1
(en)
|
2005-01-12 |
2006-07-20 |
Massachusetts Institute Of Technology |
Methods and compositions related to modulating the extracellular stem cell environment
|
EP1885865A4
(en)
|
2005-05-12 |
2010-12-22 |
Univ North Carolina |
ENZYMATIC SYNTHESIS OF SULFATED POLYSACCHARIDES
|
EP1853032B1
(en)
|
2005-07-05 |
2009-12-23 |
Huawei Technologies Co., Ltd. |
An authentication method for the ip multimedia subsystem
|
CA2652205A1
(en)
|
2006-05-25 |
2007-12-06 |
Mallik Sundaram |
Low molecular weight heparin composition and uses thereof
|
US20090035787A1
(en)
|
2007-07-23 |
2009-02-05 |
The University Of North Carolina At Chapel Hill |
Enzymatic synthesis of sulfated polysaccharides without iduronic acid residues
|
EP2207811B1
(en)
|
2007-11-02 |
2017-01-04 |
Momenta Pharmaceuticals, Inc. |
Non-anticoagulant polysaccharide compositions
|
WO2009059284A2
(en)
|
2007-11-02 |
2009-05-07 |
Momenta Pharmaceuticals, Inc. |
Non-anticoagulant polysaccharide compositions
|
JP2011526925A
(ja)
|
2008-07-01 |
2011-10-20 |
ザカロン ファーマシューティカルズ,インク. |
ヘパラン硫酸阻害剤
|
CN104245718B
(zh)
|
2009-07-31 |
2016-11-09 |
可靠生物医药公司 |
制备磺达肝素钠的方法及其合成中使用的中间体
|
CN101724086B
(zh)
|
2009-11-25 |
2012-09-26 |
深圳海王药业有限公司 |
低聚凤梨参糖胺聚糖及其制备方法
|
WO2012088416A2
(en)
*
|
2010-12-23 |
2012-06-28 |
The University Of North Carolina At Chapel Hill |
Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparins
|
WO2012116048A1
(en)
|
2011-02-22 |
2012-08-30 |
Rensselaer Polytechnic Institute |
Single step heparosan n-deacetylation and depolymerization for making bioengineered heparin
|
US8815529B2
(en)
|
2011-05-23 |
2014-08-26 |
Research & Diagnostics Systems, Inc. |
Sulfotransferase assay
|
WO2013149161A1
(en)
|
2012-03-30 |
2013-10-03 |
Deangelis Paul L |
High molecular weight heparosan polymers and methods of production and use thereof
|
CN102660610A
(zh)
*
|
2012-05-31 |
2012-09-12 |
江南大学 |
一种酶法制备高活性低分子量肝素的方法
|
US20140349962A1
(en)
|
2013-05-24 |
2014-11-27 |
Massachusetts Institute Of Technology |
Rapid two-step synthesis of anti-coagulants
|
EP3011043B1
(en)
|
2013-06-17 |
2022-05-11 |
The University of North Carolina At Chapel Hill |
Reversible heparin molecules
|
US20170226543A1
(en)
|
2014-08-22 |
2017-08-10 |
Danmarks Tekniske Universitet |
Biological processes for the production of aryl sulfates
|
JP6879216B2
(ja)
*
|
2015-12-28 |
2021-06-02 |
味の素株式会社 |
抗凝固活性を有するヘパラン硫酸の製造法
|
CN109072262A
(zh)
|
2016-02-24 |
2018-12-21 |
丹麦技术大学 |
用于生产芳基硫酸酯的改进的生物方法
|
TWI769176B
(zh)
|
2016-09-07 |
2022-07-01 |
瑞瑟勒綜合技術協會 |
生合成肝素
|
WO2018135027A1
(ja)
|
2017-01-19 |
2018-07-26 |
味の素株式会社 |
ヘキスロン酸残基が異性化されたヘパロサン化合物の製造方法
|
CN110446511B
(zh)
|
2017-03-10 |
2024-04-02 |
北卡罗来纳大学查珀尔希尔分校 |
短效的基于肝素的抗凝血剂化合物和方法
|
JP7200948B2
(ja)
|
2017-09-05 |
2023-01-10 |
味の素株式会社 |
2-o-硫酸化酵素変異体、および3-o-硫酸化酵素変異体、ならびにそれらを用いる方法
|
CN108220365A
(zh)
*
|
2018-01-16 |
2018-06-29 |
浙江海洋大学 |
一种提高肝素抗凝血活性的方法
|
EP3911737A1
(en)
*
|
2019-01-15 |
2021-11-24 |
Optimvia, LLC |
Engineered aryl sulfate-dependent enzymes
|